Alcon Net Income 2019-2022 | ALC
Alcon annual/quarterly net income history and growth rate from 2019 to 2022. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
- Alcon net income for the quarter ending September 30, 2022 was $0.116B, a 5700% increase year-over-year.
- Alcon net income for the twelve months ending September 30, 2022 was $571M, a 71.99% increase year-over-year.
- Alcon annual net income for 2021 was $0.376B, a 170.81% decline from 2020.
- Alcon annual net income for 2020 was $-0.531B, a 19.05% decline from 2019.
- Alcon annual net income for 2019 was $-0.656B, a 188.99% increase from 2018.
Alcon Annual Net Income
(Millions of US $) |
| 2021 |
$376 |
| 2020 |
$-531 |
| 2019 |
$-656 |
| 2018 |
$-227 |
Alcon Quarterly Net Income
(Millions of US $) |
| 2022-09-30 |
$116 |
| 2022-06-30 |
$148 |
| 2022-03-31 |
$168 |
| 2021-12-31 |
$139 |
| 2021-09-30 |
$2 |
| 2021-06-30 |
$151 |
| 2021-03-31 |
$84 |
| 2020-12-31 |
$95 |
| 2020-09-30 |
$-147 |
| 2020-06-30 |
$-422 |
| 2020-03-31 |
$-57 |
| 2019-12-31 |
$-91 |
| 2019-09-30 |
$-66 |
| 2019-06-30 |
$-390 |
| 2019-03-31 |
$-109 |
| 2018-12-31 |
|
| 2018-09-30 |
$-207 |
| 2018-06-30 |
$15 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical Instruments Manufacturing |
$37.369B |
$8.291B |
|
Alcon Inc. researches, develops, manufactures, distributes, and sells a full suite of eye care products. Alcon operates within two segments, Surgical and Vision Care. The Surgical segment is focused on ophthalmic products for cataract surgery, vitreoretinal surgery, refractive laser surgery and glaucoma surgery, and includes implantables, consumables, and surgical equipment required for these procedures. The Vision Care segment comprises daily disposable, reusable and color-enhancing contact lenses, and a comprehensive portfolio of ocular health products, including products for dry eye, contact lens care, and ocular allergies, as well as ocular vitamins and redness relievers.
|
